| Basics |
Bio-Techne Corp
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.
|
| IPO Date: |
March 1, 1989 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$7.63B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.49 | 1.14%
|
| Avg Daily Range (30 D): |
$0.88 | 1.77%
|
| Avg Daily Range (90 D): |
$1.24 | 2.13%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.25M |
| Avg Daily Volume (30 D): |
1.89M |
| Avg Daily Volume (90 D): |
1.7M |
| Trade Size |
| Avg Trade Size (Sh.): |
63 |
| Avg Trade Size (Sh.) (30 D): |
59 |
| Avg Trade Size (Sh.) (90 D): |
58 |
| Institutional Trades |
| Total Inst.Trades: |
6,647 |
| Avg Inst. Trade: |
$4.92M |
| Avg Inst. Trade (30 D): |
$5.23M |
| Avg Inst. Trade (90 D): |
$4.5M |
| Avg Inst. Trade Volume: |
.32M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$8.34M |
| Avg Closing Trade (30 D): |
$22.85M |
| Avg Closing Trade (90 D): |
$17.77M |
| Avg Closing Volume: |
408.02K |
|
|
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.84
|
$.14
|
|
|
Diluted EPS
|
$.83
|
$.14
|
|
|
Revenue
|
$ 1.21B
|
$ 316.18M
|
$
|
|
Gross Profit
|
$ 794.81M
|
$ 214.56M
|
$
|
|
Net Income / Loss
|
$ 131.67M
|
$ 22.59M
|
$ 34.89M
|
|
Operating Income / Loss
|
$ 171.94M
|
$ 38.71M
|
$
|
|
Cost of Revenue
|
$ 413.96M
|
$ 101.63M
|
$
|
|
Net Cash Flow
|
$ -3.09M
|
$
|
$
|
|
PE Ratio
|
58.27
|
|
|
| Splits |
|
Nov 30, 2022:
4:1
|
|
Nov 10, 2022:
4:1
|
|
Dec 04, 2000:
2:1
|
|
